News
ThriveRx to distribute Gattex, a new treatment approved by the FDA for adults with short bowel syndrome who are dependent on parenteral support.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback